Insights
Practical articles for pharma procurement, QA and R&D teams — compliance updates, supply chain strategy and green chemistry developments.
New Injectable API Product Lines — Indocyanine Green, Lidocaine and More — Expanding Our Export Portfolio
The company has completed a strategic expansion of its product portfolio, officially adding clinically essential injectable-grade APIs including Indocyanine Green for Injection, Lidocaine Hydrochloride and Gentamicin Sulfate, while completing formulation OEM contract-manufacturing registration documentation. Backed by mature end-to-end capabilities in export customs declaration, commodity inspection and customs clearance, we offer overseas customers a one-stop service of API supply + formulation contract manufacturing + registration dossier support, meeting hospital pharmacy and pharma mass-production needs across multiple countries.
Green Chemistry & Sustainable Manufacturing at Xi'an Greday Biological Technology
How Xi'an Greday Biological Technology is investing in continuous-flow reactors, solvent recovery systems and renewable energy to cut environmental impact while maintaining the highest API intermediate quality.
Tirzepatide and Orforglipron
"Xi'an Greday Biological Technology has completed small-scale synthesis and purity calibration of Tirzepatide and Orforglipron APIs, and can supply API powder, formulation development support and pilot-scale contract manufacturing, entering the GLP-1 innovative API market."
Navigating ICH Q7 & Chinese GMP: A Practical Checklist for Global Buyers
A buyer's guide to auditing pharmaceutical suppliers in China — what ICH Q7 and CNDA GMP certifications actually mean, and the red flags to watch for.
Supply Chain Resilience: Diversifying Your API Intermediate Base
Lessons from post-pandemic supply shocks — why western pharma is again qualifying dual-source partners for critical API intermediates, and how Xi'an Greday Biological Technology supports that strategy.
Xi'an Greday Biological Technology at CPHI China, Expanding Middle East Pharmaceutical Channels
The 21st CPHI China exhibition in Shanghai concluded successfully. Xi'an Greday Biological Technology focused on the essential-demand pharmaceutical markets of the Middle East, highlighting sterile injectable APIs and oral formulation contract manufacturing services, and engaged on-site with local pharmaceutical distributors and formulation manufacturers from Saudi Arabia, the UAE and Iraq. Following the exhibition, fixed distribution partnerships were established in Jeddah (Saudi Arabia) and Kuwait — two core regional hubs — achieving a channel breakthrough from zero to one in the Middle East and further expanding our overseas sales footprint.
Xi'an Greday Biological Technology Officially Registered, Anchored in API Export and Pharmaceutical CDMO
Xi'an Greday Biological Technology (Xi'an Greday Biological Technology) has recently completed business registration in Xi'an. Positioned around high-quality API export, customized CDMO API contract manufacturing, and injectable OEM production, the company is rooted in Shaanxi while building a global pharmaceutical supply chain business. In its founding stage, it deeply engaged pharmaceutical research resources in Northwest China and university-enterprise joint laboratories, establishing three foundational systems — API sourcing, quality testing, and export documentation compliance — laying a solid foundation for global expansion.